Clinical Trials Directory

Trials / Unknown

UnknownNCT02937207

Study on the Treatment of Bronchial Asthma With Traditional Chinese Medicine

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
288 (estimated)
Sponsor
Shanghai University of Traditional Chinese Medicine · Academic / Other
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to evaluate the clinical efficacy of traditional Chinese medicine in the treatment of asthma, and to promote the application in community hospitals.

Detailed description

Asthma is a serious global health problem and has increasing prevalence in many countries.Although asthma symptoms can be controlled by drug treatment to a large extent, there is still inadequate.Traditional Chinese medicine has a long history of treating asthma, and has a good clinical curative effect.The purpose of this study is to evaluate the clinical efficacy of traditional Chinese medicine in the treatment of asthma, and to promote the application in community hospitals. This could constitute a significant advance in asthma management. In this study, the investigators recruited patients with asthma exacerbation and remission stage, and gave the corresponding western medicine background treatment and traditional Chinese medicine treatment program.Participants will undergo a physical examination, lung function, blood and sputum collection. Exacerbation group belongs to cold type of asthma patients will take Ke Chuan Liu Wei Mixture, wind phlegm type of asthma patients will take Chuan Xiong Ping Chuan Mixture and Xie Wu Capsule,and hot type of asthma patients will take Dan Ma Jia Tablet for 14 days treatment, while the 3 control groups were given 3 corresponding placebo treatment for a total of 14 days. Remission phase of Yang deficiency patients in treatment group will take Zhi Chuan Capsule and Bu Shen Na Qi Granule, and in control group received a placebo treatment for a total of 60 days. Study visits will occur for 7 days of exacerbation group and 1 year for remission group. Questionnaires to assess asthma control will be completed during study of asthma at exacerbation stage within 44 days and on remission period within 12 months.

Conditions

Interventions

TypeNameDescription
DRUGKe Chuan Liu Wei MixtureExperience formula of famous traditional Chinese professor Yingen Wu
DRUGChuan Xiong Ping Chuan MixtureExperience formula of famous traditional Chinese professor Changrong Shao
DRUGXie Wu CapsuleExperience formula of famous traditional Chinese professor Jianhua Hu
DRUGDan Ma Jia TabletExperience formula of famous traditional Chinese professor Xiaopu Xu
DRUGZhi Chuan CapsuleExperience formula of famous traditional Chinese professor Yingen Wu
DRUGBu Shen Na Qi GranuleExperience formula of famous traditional Chinese professor Changrong Shao
DRUGKe Chuan Liu Wei Mixture placeboLow dose combination for treating prescription of Ke Chuan Liu Wei Mixture
DRUGChuan Xiong Ping Chuan Mixture placeboLow dose combination for treating prescription of Chuan Xiong Ping Chuan Mixture
DRUGXie Wu Capsule placeboLow dose combination for treating prescription of Xie Wu Capsule
DRUGDan Ma Jia Tablet placeboLow dose combination for treating prescription of Dan Ma Jia Tablet
DRUGZhi Chuan Capsule placeboLow dose combination for treating prescription of Zhi Chuan Capsule
DRUGBu Shen Na Qi Granule placeboLow dose combination for treating prescription of Bu Shen Na Qi Granule

Timeline

Start date
2017-07-30
Primary completion
2020-12-01
Completion
2021-12-01
First posted
2016-10-18
Last updated
2020-02-26

Locations

5 sites across 1 country: China

Source: ClinicalTrials.gov record NCT02937207. Inclusion in this directory is not an endorsement.